Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic

Am J Public Health. 2021 Mar;111(3):355-358. doi: 10.2105/AJPH.2020.306036. Epub 2020 Nov 25.

Authors

Sandra Crouse Quinn¹, Amelia M Jamison¹, Vicki Freimuth¹

Affiliation

¹ Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.

No abstract available

MeSH terms

COVID-19 / epidemiology*
COVID-19 / prevention & control*
COVID-19 Vaccines / supply & distribution*
Cultural Competency
Health Communication / methods*
Health Communication / standards
Humans
Pandemics
SARS-CoV-2
Trust
United States
United States Food and Drug Administration / organization & administration*
United States Food and Drug Administration / standards

Substances

COVID-19 Vaccines

Grants and funding

P20 MD006737/MD/NIMHD NIH HHS/United States